You may also notice some injection site reactions like pain, swelling, or redness
Adverse events were mainly gastrointestinal, and these were more common with orforglipron than with semaglutide ( Table 1 )
The Importance of Rotating Injection Sites It is very tempting to stick to one spot if you find an area that feels painless
As with any peptide therapy, working with a qualified provider ensures that dosage, frequency, and any side effects are carefully managed
Orforglipron works in a similar way to other GLP-1 treatments, helping regulate appetite and reduce food intake
Avg Weight Loss CV Event Reduction Published Studies Half-Life Average body weight reduction of 14.9% over 68 weeks The STEP 1 trial demonstrated that weekly semaglutide 2.4mg produced a mean weight loss of 14.9% compared to 2.4% with placebo, establishing a new benchmark in obesity research